Press Releases
New subgroup analysis of the LUX-Lung 1 trial suggests benefit from afatinib in lung cancer patients
New data to be presented show that afatinib (BIBW 2992) leads to a significant four-fold extension (4.4 months vs. 1 month for placebo) in...
News
Fluxion Biosciences Announces Product Launch of BioFlux 1000Z
Fuxion Biosciences, Inc. announced that the new BioFlux 1000Z system for live cell imaging will be launched at the 50th American Society for Cell...
Press Releases
The R and D Leaders Band Together at Discovery Summit 2011 to Uncover Innovative Solutions
The Discovery Summit 2011, presented by marcus evans, will be taking place from 21-23 March 2011 in Cannes, France. Confronted by compound challenges the...
Drug Research
Pfizer Announces Phase 3 Results of Investigational Compound Bosutinib
Pfizer Inc. announced that a significantly higher proportion of patients with newly diagnosed chronic myeloid leukemia who were treated with bosutinib (39 percent) experienced...
Press Releases
Phase 2 Interim Data Show High Objective Response Rate for Patients Treated with Elotuzumab plus
Abbott and Bristol-Myers Squibb Company announced interim results from the Phase 2 portion of a Phase 1b/2 open-label study which showed a high objective...
News
GSK signs agreement to acquire Nanjing MeiRui Pharmaceuticals
GlaxoSmithKline plc announced that it has entered into an agreement to acquire Nanjing MeiRui Pharma Co., Ltd (MeiRui) for a cash consideration of approximately...
Industry Reports
IMS Health Forecasts Global Pharmaceutical Market Growth of 5-7 Percent in 2011, Reaching $880 Billion
The value of the global pharmaceutical market is expected to grow 5-7 percent in 2011, to US$880 billion, compared with a 4-5 percent pace...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read